HER2-specific T cells

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein
US 10414812 B2申请人: UNIV PENNSYLVANIA优先权: 2015
US
WO
8 件公开
UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
EP 3250695 B1申请人: BAYLOR COLLEGE MEDICINE优先权: 2015
EP
US
WO
7 件公开
Methods for therapeutic vaccination
US 7005498 B1申请人: PHARMEXA AS优先权: 2001
US
5 件公开
MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AND METHODS OF USE
EP 4249067 A3申请人: DRAGONFLY THERAPEUTICS INC优先权: 2018
EP
US
2 件公开
HLA binding peptides and their uses
US 2009012004 A1申请人: IDM PHARMA INC优先权: 2007
US
HER2/NEU SPECIFIC T CELL RECEPTORS
US 2011280894 A1申请人: KRACKHARDT ANGELA优先权: 2008
US
Novel anti-breast cancer polypeptide vaccine
CN 102475886 A申请人: UNIV NANKAI优先权: 2010
CN
Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
US 2014154253 A1申请人: ZYMEWORKS INC优先权: 2013
US
Methods for monitoring CD4+ t-helper type 1 response in cancer and immune restoration
- CN 107073038 A
  申请人: CZERNIECKI BRIAN J优先权: 2014
  CN
- CN 107533065 A
  申请人: CZERNIECKI BRIAN J优先权: 2015
  CN
IMMUNOTHERAPY TARGETING KRAS OR HER2 ANTIGENS
CN 112912387 A申请人: HUTCHINSON FRED CANCER RES优先权: 2018
CN